COX-1 sparing drugs in aspirin-sensitive asthma

Clinical and Experimental Allergy

Volumn 31, Issue 2, 2001, Pages 179-181

  Picado, C ^a   Valero, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; ROFECOXIB;

ASTHMA; DRUG RESEARCH; DRUG SENSITIVITY; EDITORIAL; ENZYME INHIBITION; HUMAN; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HUMANS; ISOENZYMES; LEUKOTRIENE C4; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0035086629     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2001.01101.x     Document Type: Editorial

References (26)

1. Nomenclature for COX-2 inhibitors
2. Aspirin and other anti-inflammatory drugs
3. Aspirin-induced asthma: Advances in pathogenesis and management
4. The cyclooxygenase theory of aspirin-induced asthma
5. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma
6. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients
7. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthmatics
8. Aspirin-sensitive asthma: The effect of aspirin on the release of prostaglandins from nasal polyps
9. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics
10. Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients
11. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma
12. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge
13. Release of peptide leukotriene into nasal secretions after local instillation of aspirin-sensitive asthmatic patients
14. The nose in aspirin-sensitive asthma
15. Efficacy of a leukotriene receptor antagonist in bronchial responsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma
16. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation
17. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects
18. The diagnosis of aspirin idiosyncrasy by analgesic challenge
19. Acetaminophen and aspirin challenges in subgroups of asthmatics
20. Long-term tolerability of nimesulide and acetaminophen in nonsteroidal anti-inflammatory drug-intolerant patients
21. Nimesulide as alternative treatment in patients with nonsteroidal anti-inflammatory drug intolerance
22. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance
23. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin
24. Relative safety of meloxicam in NSAID-intolerant patients
25. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti-inflammatory drugs
26. Safety of a specific COX-2 inhibitor in aspirin-induced asthma